Symbols

GRDX

GridAI Technologies·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About GRDX

Gridai Technologies Corp.

AI+energy management innovator,using intelligent platforms to safeguard data center power efficiency and reliability

Industry

Pharmaceutical

Established Date

01/30/2014

Listing Date

10/11/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.enterothera.com

Security Type

Common stock

Office address

79014th St N # 21135 St. Petersburg Florida 33702

Business

Introduction

GridAI Technologies Corp. (formerly Entero Therapeutics, Inc.) was incorporated in Delaware on January 30, 2014. The company is committed to developing targeted, non-systemic, non-absorbent therapies for patients with gastrointestinal diseases that work locally in the intestinal cavity, skin or mucous membranes without entering the systemic circulation. In addition to biotech projects, the company also operates Grid AI (artificial intelligence-driven energy technology platform), which was acquired on September 30, 2025. The platform controls utility companies, retail energy suppliers and large power users, enabling them to dynamically manage load and distributed energy, including battery energy storage systems.

Company Financials

EPS

GRDX has released its 2025 Q2 earnings. EPS was reported at -0.21, versus the expected 0, missing expectations. The chart below visualizes how GRDX has performed over recent quarters, highlighting trends in earnings surprises.